Owkin
Owkin builds AI agents for biopharma R&D, led by K Pro, which it positions as connecting research and care using multimodal patient data and wet-lab validation.
About
Owkin develops autonomous AI technology for biopharmaceutical research and clinical support. Its main product, K Pro, is presented as an AI agent connecting research and care, producing insights across the R&D process. The company aims to automate drug discovery and development by combining multimodal patient data with wet-lab validation. Its site names related ventures including Epkin, Waiv and Bioptimus, and offers a press kit and policy pages.
- Organization type
- ai company
- Headquarters region
- Paris
- Founded
- Not stated
- Listings in the graph
- 0
- Last updated
- 6 October 2026
- Published
- 6 October 2026
Data sources & provenance
Where this information came from, how it was checked and when it was last looked at. “Last updated” records a change to the record — it does not mean the record was verified.
- Data quality
- Data quality: Editorially Reviewed
- Primary source
- owkin.com
- Sources cited
- 2
- Last reviewed
- 6 October 2026
- Last updated
- 6 October 2026
Spotted something out of date?
Anyone can suggest a correction — you don't need an account. An editor checks every suggestion against the sources before the record changes.
Products & technologies
No published products from this organization yet.
Services
No published services from this organization yet.
News & insights from this region
No related coverage published yet.
Events in this region
Learning resources
No learning resources from this provider yet.
Is this your organization?
Claim this profile to keep the description, products and services accurate, or add an organization that is missing from the graph.